TY PHAR. stated on the interactive platform that according to the "Diagnosis and Treatment Plan for Chikungunya Fever" issued by the National Health Commission and the National Administration of Traditional Chinese Medicine on July 31, 2025, chikungunya fever is clinically characterized by fever, joint pain, and rash, with symptomatic supportive treatment being the primary approach. For those with persistent high fever or unbearable acute joint pain, acetaminophen can be used. The acetaminophen tablets currently produced and sold by the company are suitable for the above symptoms, and patients should follow medical advice based on their actual situation. In the future, the company will fully ensure the market supply of acetaminophen tablets and other related drugs according to market demand, actively fulfilling its social responsibility with stable drug quality and sufficient production capacity
